Compugen Ltd
NASDAQ:CGEN 4:00:00 PM EDT
Market Cap (Intraday) | 227.41M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $2.59 |
50-Day MA | $2.43 |
200-Day MA | $1.41 |
Compugen Ltd Stock, NASDAQ:CGEN
Azrieli Center, 26 Harokmim Street, Holon, Tel Aviv 58858
Israel
Phone: +972.3.765.8585
Number of Employees: 68
Description
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.